Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Topical antifungal agent NB-002 under clinical development for distal subungual onychomycosis

March 12, 2010

Hedgehog pathway antagonist GDC-0449 shows clinical promise in metastatic basal cell carcinoma

March 12, 2010

Thymosin beta-4 improves neurological outcome in rat model of stroke

March 11, 2010

Albumin therapy to be evaluated in acute ischemic stroke in ongoing phase III trial

March 11, 2010

Preclinical studies point to potential of NB-003 in treating acne

March 11, 2010

Enrollment begins in phase IIb trial of NTx-265 in acute ischemic stroke

March 10, 2010

Topical WBI-1001 improves atopic dermatitis in double-blind trial

March 10, 2010

Adalimumab improves quality of life in Crohn's disease patients

March 10, 2010

New Pim kinase inhibitor ARRY-770 reduces airway hyperresponsiveness in mice

March 10, 2010

BFPT-2603 safe and efficacious in monkey model of allergic asthma

March 9, 2010

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...